Michael Schwarz at Medical University of Vienna - Research Interests, Publications & Academic Profile

Michael Schwarz

Medical University of Vienna

Austria

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Vietnamese students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Internal Medicine

70%

Pharmacotherapy

50%

Liver Fibrosis

70%

Fatty Liver

50%

Nafld

50%

Hepatocellular Carcinoma

40%

Antiviral Therapy

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles19

Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertension

Article Link

Year:

2024

Insulin‐like growth factor‐1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver‐related mortality

Article Link

Year:

2024

High histamine levels are associated with acute‐on‐chronic liver failure and liver‐related death in patients with advanced chronic liver disease

Article Link

Year:

2024

Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta

Article Link

Year:

2024

Diagnostic and prognostic performance of the LiverRisk score in tertiary care☆

Article Link

Year:

2024

Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient.

Article Link

Year:

2024

The deep abdominal ultrasound transducer (DAX) increases the success rate and diagnostic accuracy of shear wave elastography for liver fibrosis assessment in patients with obesity—A prospective biopsy‐controlled study

Article Link

Year:

2024

Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosis

Article Link

Year:

2024

Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortality

Article Link

Year:

2024

An impaired pituitary–adrenal signalling axis in stable cirrhosis is linked to worse prognosis

Article Link

Year:

2023

Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression

Article Link

Year:

2023

Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes

Article Link

Year:

2023

CHIME - A tailored HCV microelimination project in Viennese people who inject drugs at drug centralized substitution centers

Article Link

Year:

2023

Diffuse idiopathic skeletal hyperostosis as a cause for dysphagia in a patient with ankylosing spondylitis

Article Link

Year:

2023

Endoscopic band ligation is safe despite low platelet count and high INR

Article Link

Year:

2023

Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy

Article Link

Year:

2023

Immediate-type hypersensitivity reaction to bulevirtide and successful desensitization in a patient with HBV/HDV-associated compensated cirrhosis

Article Link

Year:

2022

HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease

Article Link

Year:

2021

Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patients

Article Link

Year:

2021

Collaborators7

Teresa Binter

Medical University of Vienna

AUSTRIA

Georg Semmler

Medical University of Vienna

AUSTRIA

Lorenz Balcar

Medical University of Vienna

AUSTRIA

Michael Trauner

Professor of Medicine and Chair of Gastroenterology and Hepatology

Medical University of Vienna

AUSTRIA

Jeremy V Camp

Medical University of Vienna

AUSTRIA

Benedikt Simbrunner

Medical University of Vienna

AUSTRIA

Thomas Reiberger

Medical University of Vienna

AUSTRIA

How do Vietnamese students reach out?

Meet Kite AI